|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the Centers for Disease Control and Prevention (CDC). CDC and National Institutes of Health (NIH) both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
With focused participation from both the Centers for Medicare and Medicaid Services (CMS) and experts across the National Institutes of Health (NIH), the Opioids Work Group (OWG) is designed to accelerate collaboration between these two HHS Operating Divisions related to addressing the U.S. opioid crisis.
|
|
Cervical Cancer Moonshot Federal Interagency Partners Team
|
Committee, Work group, Advisory group, or Task Force
|
HRSA, CDC
|
OD/DPCPSI/ORWH
|
The National Cancer Institute (NCI) is generating risk estimates that inform cervical screening and management guidelines. NCI is working with CDC, HRSA, and FDA to collect study populations, conduct risk estimation, and disseminate guidelines.
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
NCI
|
The National Cancer Institute (NCI) is generating risk estimates that inform cervical screening and management guidelines. NCI is working with CDC, HRSA, and FDA to collect study populations, conduct risk estimation, and disseminate guidelines.
|
|
CFAR Diversity, Equity, Inclusion Pipeline Initiative (CDEIPI)
|
Research Initiative
|
OASH
|
NIAID, NIMH, NCI, NHLBI, NIDDK, NINR, NIDCR, NIMHD, NICHD, NIA, FIC, OD/DPCPSI/OAR
|
The overarching goal of the NIH-supported CFAR Diversity, Equity, and Inclusion Pipeline Initiative (CDEIPI) is to increase the number of Underrepresented Minorities (URM) / Black, Indigenous, and People of Color (BIPOC) trainees who are engaged in HIV science at the high school, undergraduate, graduate (masters, doctoral or medical) and post-doctoral levels and to develop pathways for these "CFAR Scholars" to successful careers in science and medicine. OASH provided key information and advice in the development of this initiative.
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of the National Institute of Allergy and Infectious Diseases (NIAID) ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies.
|
|
Chronic Kidney Disease Surveillance System
|
Health Survey
|
CDC
|
NIDDK
|
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) assists the Centers for Disease Control and Prevention (CDC) in its surveillance program of chronic kidney disease, including taking part in an Advisory Group to provide feedback on the program.
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
NCI
|
In a stratified cohort study of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), restricted to postmenopausal women not on menopausal hormone therapy, researchers are using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay recently developed by the Centers for Disease Control and Prevention (CDC) to assess pre-diagnostic circulating levels of the endogenous steroid hormones believed to be involved in breast cancer etiology. Although it is known that endogenous hormones play a critical role in the etiology of breast cancer, the interrelationships among estrogens, androgens, and progesterone in determining risk are not well understood.
|
|
CISA: Clinical Immunization Safety Assessment Network (CISA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID, NHLBI
|
Subcommittee to evaluate myocarditis after COVID vaccination
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
Collaboration between Fenton lab at NIEHS and Soto lab at Tufts University to study BPA effects on mammary gland
|